EXCALIBER - Maintenance

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)

Near Add Your Location

Sorting 47 by

University Cancer and Blood Center
Athens, GA
  • Accepting patients
  • Show Principal Investigator
Herbert Irving Comprehensive Cancer Center (Columbia University)
Columbia University Medical Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
NYU Langone - Long Island
Mineola, NY
  • Accepting patients
  • Show Principal Investigator
Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Accepting patients
  • Show Principal Investigator
Fox Chase Cancer Center
Temple Health
Philadelphia, PA
  • Accepting patients
  • Show Principal Investigator
Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Accepting patients
  • Show Principal Investigator
UPMC Hillman Cancer Center
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA
  • Accepting patients
  • Show Principal Investigator
MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Accepting patients
  • Show Principal Investigator
University of Massachusetts Medical School
Worcester, MA
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.